Eargo Inc. (EAR): Price and Financial Metrics
EAR Price/Volume Stats
Current price | $2.57 | 52-week high | $8.48 |
Prev. close | $2.68 | 52-week low | $1.47 |
Day low | $2.56 | Volume | 201,300 |
Day high | $2.64 | Avg. volume | 23,347 |
50-day MA | $2.62 | Dividend yield | N/A |
200-day MA | $3.28 | Market Cap | 53.36M |
EAR Stock Price Chart Interactive Chart >
EAR POWR Grades
- EAR scores best on the Sentiment dimension, with a Sentiment rank ahead of 87.2% of US stocks.
- EAR's strongest trending metric is Value; it's been moving up over the last 27 days.
- EAR ranks lowest in Quality; there it ranks in the 3rd percentile.
EAR Stock Summary
- With a year-over-year growth in debt of -94.64%, EARGO INC's debt growth rate surpasses merely 0.97% of about US stocks.
- The volatility of EARGO INC's share price is greater than that of 88.43% US stocks with at least 200 days of trading history.
- EARGO INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -61.59%, greater than the shareholder yield of just 6.73% of stocks in our set.
- Stocks that are quantitatively similar to EAR, based on their financial statements, market capitalization, and price volatility, are HEAR, WRAP, PLAB, REFR, and ECOR.
- EAR's SEC filings can be seen here. And to visit EARGO INC's official web site, go to eargo.com.
EAR Valuation Summary
- EAR's EV/EBIT ratio is -0.1; this is 100.68% lower than that of the median Healthcare stock.
- EAR's price/sales ratio has moved down 34.8 over the prior 39 months.
Below are key valuation metrics over time for EAR.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
EAR | 2023-12-29 | 1.3 | 1.2 | -0.5 | -0.1 |
EAR | 2023-12-28 | 1.3 | 1.2 | -0.5 | -0.1 |
EAR | 2023-12-27 | 1.3 | 1.2 | -0.5 | -0.1 |
EAR | 2023-12-26 | 1.3 | 1.2 | -0.5 | -0.1 |
EAR | 2023-12-22 | 1.3 | 1.2 | -0.5 | -0.1 |
EAR | 2023-12-21 | 1.3 | 1.2 | -0.5 | -0.1 |
EAR's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- EAR has a Quality Grade of D, ranking ahead of 9.8% of graded US stocks.
- EAR's asset turnover comes in at 0.45 -- ranking 106th of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows EAR's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.450 | 0.710 | -3.415 |
2020-12-31 | 0.532 | 0.684 | -4.861 |
EAR Price Target
For more insight on analysts targets of EAR, see our EAR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $55.33 | Average Broker Recommendation | 2 (Hold) |
Eargo Inc. (EAR) Company Bio
Eargo, Inc. develops next generation hearing aids and headsets solutions. It offers Eargomax, a new chip for maximum audio fidelity and noise reduction and Eargoplus a superior hearing technology designed for first time hearing aid users. The company was founded by Florent Michel, Raphael Michel and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.
Latest EAR News From Around the Web
Below are the latest news stories about EARGO INC that investors may wish to consider to help them evaluate EAR as an investment opportunity.
Eargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and InnovationSAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo”) celebrates the one-year anniversary of the creation of an over-the-counter (OTC) hearing aid category in the US. This important advancement by the US Food & Drug Administration (FDA), following a bipartisan mandate from Congress, was meant to reduce costs, increase competition, improve access, and drive innovation in the hearing aid category, resulting in more widespread adoption of hearing technology. This f |
Why Is Eargo (EAR) Stock Up 50% Today?EAR stock is in focus on take-private news. |
Eargo Expands Relationship with Best Buy, Growing In-Store Presence to Over 500 LocationsSAN JOSE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced an expansion of its relationship with Best Buy. Eargo devices are now on display in more than 500 Best Buy stores, marking another step in Eargo’s retail journey. Approximately 250 of these Best Buy locations will carry Eargo 5–an over-the-counter, FDA-cleared and self-fitting hearing aid–allowing customer |
Eargo Reports Second Quarter 2023 Financial ResultsRecent Highlights: Net revenues of $8.1 million in the second quarter of 2023, up 12% year-over-yearGross systems shipped of 5,098, up 14% year-over-yearGAAP total operating loss $25.8 million in the second quarter of 2023, compared to $31.4 million in the second quarter of 2022In connection with the implementation of the announced cost reduction plan, the Company expects to extend net operating cash runway into the second half of 2024 SAN JOSE, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Eargo, I |
Q1 2023 Eargo Inc Earnings CallQ1 2023 Eargo Inc Earnings Call |
EAR Price Returns
1-mo | N/A |
3-mo | -0.39% |
6-mo | 16.82% |
1-year | -35.75% |
3-year | -99.73% |
5-year | N/A |
YTD | -0.77% |
2023 | -77.48% |
2022 | -88.73% |
2021 | -88.62% |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...